Novartis shutters MorphoSys sites, lays off staff. The pharma company said it's merging “all portfolio activities” into Novartis, but remains...
6 months ago

Novartis has revealed a safety signal that could set back plans to seek approval for the jewel of the acquisition by a couple of years.
7 months ago

Novartis confirmed Thursday that it's closing down MorphoSys sites in Munich and Boston and planning around 330 layoffs. The company made the...
6 months ago

The closures follow Novartis's acquisition of MorphoSys earlier this year. Novartis is closing down sites in Germany and Boston that were picked...
6 months ago

Swiss pharmaceutical group Novartis (NOVN.S) said on Thursday it was winding up MorphoSys sites in Germany and the United States, affecting 330 jobs.
6 months ago

The closures come after Novartis recorded an $800-million impairment in its third-quarter earnings related to the BET inhibitor pelabresib,...
6 months ago

Other statistics on the topic · 2025 ranking of the global leading 10 biotech and pharmaceutical companies based on revenue (in · Raised biotech...
2 months ago

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 11, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) announced today that...
1 week ago

Johnson & Johnson has announced positive topline results from its Phase 3b APEX study evaluating TREMFYA® (guselkumab) in adults with active psoriatic...
2 months ago

Novartis sheds MorphoSys staff, sites after pelabresib delay ... Novartis has said it will shut down two MorphoSys sites in Germany and the US,...
6 months ago